A prediction model for lung involvement using circulating angiotensin converting enzyme-2 and renin levels in COVID-19 patients
| dc.authorid | 0009-0000-0930-0278 | |
| dc.contributor.author | Akkan, Cansu | |
| dc.contributor.author | Das, Murat | |
| dc.contributor.author | Bardakci, Okan | |
| dc.contributor.author | Sehitoglu, Muserref Hilal | |
| dc.contributor.author | Akdur, Gokhan | |
| dc.contributor.author | Akman, Canan | |
| dc.contributor.author | Akdur, Okhan | |
| dc.date.accessioned | 2026-02-03T11:59:46Z | |
| dc.date.available | 2026-02-03T11:59:46Z | |
| dc.date.issued | 2025 | |
| dc.department | Çanakkale Onsekiz Mart Üniversitesi | |
| dc.description.abstract | Introduction: The potential role of the renin-angiotensin-aldosterone system (RAAS) in the pathogenesis of coronavirus disease 2019 (COVID-19) is controversial, with concerns mainly about the part RAAS peptides play in the prediction of progression to more severe disease. Given the importance of COVID-19 prognostication at early disease stages, we established and validated a multivariable risk stratification tool for COVID-19 associated lung involvement by utilizing a combination of RAAS peptides. Methodology: In this prospective study, circulating renin and angiotensin converting enzyme-2 (ACE-2) levels were measured in 116 COVID-19 patients who were admitted to our hospital from March 30, 2021 to January 24, 2022 and underwent a lung computed tomography (CT) scan. Clinical severity was measured with a national early warning score (NEWS). Associations among RAAS peptides, inflammation-dependent biomarkers, demographic variables, and clinical outcomes were studied using logistic regression and Cox proportional-hazards models. Results: We assessed 116 COVID-19 patients (mean age 45.1 f 12.6 years; 51.7% male), of whom 66 (56.9%) had COVID-19 associated pneumonia. Baseline circulating ACE-2 (2.63 f 0.12 ng/mL) and renin levels (85.04 f 6.8 ng/L) were lower in patients with COVID-19 related pneumonia compared to patients without pneumonia (6.4 f 0.7 ng/mL and 211.6 f 21.9 ng/L, respectively) (p < 0.001 for both). Both RAAS components were found to be significantly related to adverse outcomes, including COVID-19 associated pneumonia and intensive care unit (ICU) admission, in both crude and adjusted multivariable logistic regression analyses. Conclusions: Circulating ACE-2 and renin levels can predict lung involvement in COVID-19 patients, and they display good correlation and agreement with NEWS. | |
| dc.description.sponsorship | Scientific Research Projects Coordination Unit of Canakkale Onsekiz Mart University [TTU-2021-3685] | |
| dc.description.sponsorship | This research is supported by The Scientific Research Projects Coordination Unit of Canakkale Onsekiz Mart University (Project ID: TTU-2021-3685) . | |
| dc.identifier.doi | 10.3855/jidc.21313 | |
| dc.identifier.endpage | 1442 | |
| dc.identifier.issn | 1972-2680 | |
| dc.identifier.issue | 10 | |
| dc.identifier.pmid | 41187182 | |
| dc.identifier.scopus | 2-s2.0-105020894403 | |
| dc.identifier.scopusquality | Q3 | |
| dc.identifier.startpage | 1432 | |
| dc.identifier.uri | https://doi.org/10.3855/jidc.21313 | |
| dc.identifier.uri | https://hdl.handle.net/20.500.12428/34414 | |
| dc.identifier.volume | 19 | |
| dc.identifier.wos | WOS:001650744100001 | |
| dc.identifier.wosquality | Q4 | |
| dc.indekslendigikaynak | Web of Science | |
| dc.indekslendigikaynak | Scopus | |
| dc.indekslendigikaynak | PubMed | |
| dc.language.iso | en | |
| dc.publisher | J Infection Developing Countries | |
| dc.relation.ispartof | Journal of Infection in Developing Countries | |
| dc.relation.publicationcategory | Makale - Uluslararası Hakemli Dergi - Kurum Öğretim Elemanı | |
| dc.rights | info:eu-repo/semantics/openAccess | |
| dc.snmz | KA_WOS_20260130 | |
| dc.subject | ACE-2 | |
| dc.subject | COVID-19 | |
| dc.subject | emergency medicine | |
| dc.subject | NEWS | |
| dc.subject | pneumonia | |
| dc.subject | renin | |
| dc.title | A prediction model for lung involvement using circulating angiotensin converting enzyme-2 and renin levels in COVID-19 patients | |
| dc.type | Article |











